ASPG and acute lymphoblastic leukemia: The patient’s induction therapy was started with prednisone intravenous (60 mg/m2/day), daunorubicin per infusionem (p.i. 30 mg/m2), vincristine intravenous (1.5 mg/m2), polyethylene glycol (PEG)-asparaginase p.i. (2500 UI/m2), cyclophosphamide p.i. (1000 mg/m2), and methotrexate intra thecal (12 mg) according to the AIEOP-BFM ALL 2017 protocol IAp (International Collaborative Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia).